Article Details

PTC to sell spinal muscular atrophy drug royalties for $1B | BioPharma Dive

Retrieved on: 2023-10-19 15:57:46

Tags for this article:

Click the tags to see associated articles and topics

PTC to sell spinal muscular atrophy drug royalties for $1B | BioPharma Dive. View article details on hiswai:

Excerpt

A second deal with Royalty Pharma will allow PTC to retire Blackstone debt and keep more cash for future operations. Published Oct. 19, 2023.

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up